Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biological chemistry

• Publication date

  2000-09-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/BC.2000.114PMID 11076024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor.

  2000cited by this paper
• Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.

  2000cited by this paper
• Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

  2000cited by this paper
• Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.

  2000cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.

  1999cited by this paper
• α-Synuclein Fibrillogenesis Is Nucleation-dependent

  1999cited by this paper
• Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

  1999cited by this paper
• Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

  1999cited by this paper
• Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

  1999influential reference
• Caspase-8 is required for cell death induced by expanded polyglutamine repeats.

  1999cited by this paper
• Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

  1999cited by this paper
• SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates.

  1998cited by this paper
• A cellular model that recapitulates major pathogenic steps of Huntington's disease.

  1998cited by this paper
• Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

  1998cited by this paper
• Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch

  1998cited by this paper
• Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

  1998cited by this paper
• Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.

  1998cited by this paper
• Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

  1998cited by this paper
• Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.

  1998cited by this paper
• Intranuclear neuronal inclusions in DRPLA.

  1998influential reference
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

  1997influential reference
• Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons.

  1997cited by this paper
• Toward Understanding the Molecular Pathology of Huntington's Disease

  1997cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

  1997cited by this paper
• The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1

  1997cited by this paper
• Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997influential reference
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

  1996cited by this paper
• Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

  1996cited by this paper
• Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.

  1996cited by this paper
• Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo

  1996cited by this paper
• Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript.

  1996cited by this paper
• SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

  1995cited by this paper
• Huntington’s Disease: Recent Advances in Diagnosis and Management

  1995cited by this paper
• Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

  1995cited by this paper
• Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

  1993cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper

• Neuronal cell line expressing full-length mutant huntingtin exhibits alterations in proteolysis

  2026cites this paper
• Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues

  2025cites this paper
• Insights into Caspase-6 Mutations and Neuropathology in Huntington’s Disease and Psychiatric Disorders: A Structural Genomics and Drug Repurposing Approach

  2025cites this paper
• Quantification of Protein Secondary Structures from Discrete Frequency Infrared Images Using Machine Learning

  2025cites this paper
• Elucidating the Impact of Deleterious Mutations on IGHG1 and Their Association with Huntington’s Disease

  2024cites this paper
• Impairment of the glial phagolysosomal system drives prion-like propagation in a Drosophila model of Huntington’s disease

  2024cites this paper
• Uncovering novel polyhydroxyalkanoate biosynthesis genes and unique pathway in yeast hanseniaspora valbyensis for sustainable bioplastic production

  2024cites this paper
• Long noncoding RNAs in ubiquitination, protein degradation, and human diseases.

  2024cites this paper
• Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a Drosophila Model of Huntington's Disease

  2024cites this paper
• A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease

  2023cites this paper
• Expression of mHTT in neurons inhibits phagocytic clearance of axonal debris

  2023cites this paper
• Defective Mitochondrial Dynamics and Protein Degradation Pathways Underlie Cadmium-Induced Neurotoxicity and Cell Death in Huntington’s Disease Striatal Cells

  2023cites this paper
• Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases.

  2022cites this paper
• Molecular Pathophysiological Mechanisms in Huntington’s Disease

  2022cites this paper
• Assessment of In Vivo Muscle Force in the R6/2 Mouse Model of Huntington's Disease Using Newly Designed Force Rig

  2021cites this paper
• Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

  2021cites this paper
• A comprehensive review of the therapeutic potential of curcumin nanoformulations

  2021cites this paper
• Is pseudoexfoliation glaucoma a neurodegenerative disorder?

  2021influential citation
• Polyglutamine-Specific Gold Nanoparticle Complex Alleviates Mutant Huntingtin-Induced Toxicity.

  2021cites this paper
• Flanking regions determine the structure of the poly-glutamine homo- repeat in huntingtin through mechanisms common among glutamine-rich human proteins

  2020cites this paper
• Algorithms and Computational Tools for the Study of Intrinsically disordered proteins. (Algorithmes et outils informatiques pour l'etude des Proteines Intrinsequement Desordonnees)

  2020cites this paper
• Flanking Regions Determine the Structure of the Poly-Glutamine in Huntingtin through Mechanisms Common among Glutamine-Rich Human Proteins.

  2020cites this paper
• Role of Pre-molten Globule Structure in Protein Amyloid Fibril Formation

  2019cites this paper
• The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease

  2019cites this paper
• Molecular Dynamics simulations applied to structural and dynamical transitions of the HTT protein: A review.

  2019cites this paper
• State-of-the-Art Fluorescence Fluctuation-Based Spectroscopic Techniques for the Study of Protein Aggregation

  2018cites this paper
• Fibril branching dominates self-assembly of mutant huntingtin exon-1 aggregates in vitro

  2017cites this paper
• Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions

  2017cites this paper
• Aggregation‐induced changes in the chemical exchange saturation transfer (CEST) signals of proteins

  2017cites this paper
• PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model

  2017cites this paper
• Self-assembly of mutant huntingtin exon-1 fragments into large complex fibrillar structures involves nucleated branching

  2017cites this paper
• Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight

  2016cites this paper
• Conformational Analysis of Misfolded Protein Aggregation by FRET and Live-Cell Imaging Techniques

  2015cites this paper
• Use of Genetically Engineered Mice to Study the Biology of Huntingtin

  2015cites this paper
• Advances in Huntington Disease Drug Discovery

  2014cites this paper
• Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration.

  2014cites this paper
• Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy

  2014cites this paper
• Pathology and function of nuclear amyloid. Protein homeostasis matters.

  2014cites this paper
• Pathology and function of nuclear amyloid

  2014cites this paper
• IN SILICO AND IN VITRO ANALYSIS ABOUT EFFECTS OF THE AFFINITY TAGS ON THE RATE OF AMYLOID FIBRILATION OF PROTEINS

  2014cites this paper
• The triple power of D³: protein intrinsic disorder in degenerative diseases.

  2014cites this paper
• The Role of Trophic Factors and Other Drugs in the Treatment of Huntington's Disease in R6/2 Mouse Model

  2013cites this paper
• Metabolic States Following Accumulation of Intracellular Aggregates: Implications for Neurodegenerative Diseases

  2013cites this paper
• The Role of Trophic Factors and Other Drugs in the Treatment of Huntington ’ s Disease in R 6 / 2 Mouse Model by Jessica Ciesler

  2013cites this paper
• The role of the proteasome in Huntington’s disease

  2013cites this paper
• Sequestration of Sup35 by Aggregates of huntingtin Fragments Causes Toxicity of [PSI+] Yeast*

  2012cites this paper
• Huntington disease and the huntingtin protein.

  2012cites this paper
• Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

  2012cites this paper
• Molecular Mechanism of Huntington’s Disease — A Computational Perspective

  2012cites this paper
• Neuronal activity-dependent protection against apoptotic and oxidative insults

  2012cites this paper
• 6 Machado-Joseph Disease / Spinocerebellar Ataxia Type 3

  2012cites this paper
• Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study.

  2012cites this paper
• Ameliorating Huntington's Disease by Targeting Huntingtin mRNA

  2012cites this paper
• Machado-Joseph disease/spinocerebellar ataxia type 3.

  2012cites this paper
• Triple Repeat Diseases of the Nervous Systems

  2012cites this paper
• TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease.

  2012cites this paper
• Aggregation kinetics of interrupted polyglutamine peptides.

  2011cites this paper
• Structural characterization of polyglutamine fibrils by solid-state NMR spectroscopy.

  2011influential citation
• Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.

  2011cites this paper
• A new cloning strategy for generating multiple repeats of a repetitive polypeptide based on non-template PCR

  2011influential citation
• Polyglutamine Expansion Alters the Dynamics and Molecular Architecture of Aggregates in Dentatorubropallidoluysian Atrophy*

  2011cites this paper
• Location trumps length: polyglutamine-mediated changes in folding and aggregation of a host protein.

  2011cites this paper
• Efficient Induction of Nuclear Aggresomes by Specific Single Missense Mutations in the DNA-binding Domain of a Viral AP-1 Homolog*

  2011cites this paper
• Innovative approaches to monitor mutant huntingtin and to facilitate its degradation in Huntington's disease models

  2011cites this paper
• Effects and analysis of transglutamination on protein aggregation and clearance in neurodegenerative diseases.

  2011cites this paper
• Structural aspects of the Huntingtin protein investigated by biocomputing methods

  2011cites this paper
• Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

  2011cites this paper
• Regulation of RE1 Protein Silencing Transcription Factor (REST) Expression by HIP1 Protein Interactor (HIPPI)*

  2011cites this paper
• Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D2 concept

  2010cites this paper
• Molecular mechanisms and potential therapeutical targets in Huntington's disease.

  2010cites this paper
• Slow Degradation and Aggregation In Vitro of Mutant GABAA Receptor γ2(Q351X) Subunits Associated with Epilepsy

  2010cites this paper
• SlowDegradationandAggregationInVitroofMutant GABA A Receptor2(Q351X)SubunitsAssociatedwith Epilepsy

  2010cites this paper
• Overexpression of F(0)F(1)-ATP synthase alpha suppresses mutant huntingtin aggregation and toxicity in vitro.

  2009cites this paper
• Protein disorder in the human diseasome: unfoldomics of human genetic diseases

  2009cites this paper
• Striatal Expression of a Calmodulin Fragment Improved Motor Function, Weight Loss, and Neuropathology in the R6/2 Mouse Model of Huntington's Disease

  2009cites this paper
• The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review

  2009influential citation
• Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation.

  2009cites this paper
• Intrinsic disorder in proteins associated with neurodegenerative diseases.

  2009cites this paper
• The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

  2009cites this paper
• Crystalline, membrane-embedded, and fibrillar proteins investigated by solid-state NMR spectroscopy

  2009cites this paper
• A strategy for generating polyglutamine 'length libraries' in model host proteins.

  2008cites this paper
• The structural impact of a polyglutamine tract is location-dependent.

  2008cites this paper
• Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity

  2008cites this paper
• PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner

  2008cites this paper
• PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner

  2008cites this paper
• Protein Misfolding, a Common Mechanism in the Pathogenesis of Neurodegenerative Diseases

  2008cites this paper
• Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

  2008cites this paper
• Amyloidogenesis of natively unfolded proteins.

  2008cites this paper
• Amyloid Fibril Formation of Natively Unfolded Proteins

  2008cites this paper
• Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease.

  2008cites this paper
• IntrabodiesBindingtheProline-RichDomainsofMutant HuntingtinIncreaseItsTurnoverandReduceNeurotoxicity

  2008cites this paper
• Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3*

  2007cites this paper
• Reconsidering the mechanism of polyglutamine peptide aggregation.

  2007cites this paper
• Detection of CAG repeat DNA sequences by pyrene-functionalized pyrrole-imidazole polyamides.

  2007cites this paper
• INCLUSION FORMATION BY ATAXINS -1, -2, -3, AND -7

  2007cites this paper
• Identification of an amyloidogenic region on keratoepithelin via synthetic peptides

  2007cites this paper
• The structure of a polyQ–anti-polyQ complex reveals binding according to a linear lattice model

  2007cites this paper
• Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories.

  2007cites this paper
• Ubiquitin-interacting Motifs Inhibit Aggregation of PolyQ-expanded Huntingtin*

  2007cites this paper
• Modified single-stranded oligonucleotides inhibit aggregate formation and toxicity induced by expanded polyglutamine

  2007cites this paper